By: Benzinga
UPDATE: JP Morgan Cuts PT to $22 on VIVUS Following Q4 Report
JP Morgan maintained VIVUS (NASDAQ: VVUS ) with an Overweight rating and lowered the price target from $25.00 to $22.00. JP Morgan commented, "We are maintaining our OW rating on VVUS following yesterday's 4Q report. Updated launch metrics for the obesity drug Qsymia were generally inline with our expectations, and
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here